Pembrolizumab 395mg/2.4ml solution for injection vials
- SNOMED code
45750611000001103- Active compound
- Pembrolizumab
- Preferred name basis
- rINN - Recommended International Non-proprietary
- Prescribable
- ✅ Yes
- Dose form
- Discrete
- Dose size and units
- 2.4 ml, vial
- Ingredients
- Pembrolizumab
— 165 mg
/ 1 ml
based on ingredient substance
- Form & Route
- solutioninjection.subcutaneous
Solution for injection, Subcutaneous - Controlled drug
- No Controlled Drug Status
Products
Keytruda 395mg/2.4ml solution for injection vials (Merck Sharp & Dohme (UK) Ltd)
Keytruda 395mg/2.4ml solution for injection vials
- SNOMED code
45732911000001107- Supplier
- Merck Sharp & Dohme (UK) Ltd
- Licensed as
- Medicines - MHRA/EMA
- Availability restrictions
- None
- Licensed route
- Subcutaneous
| Pack name & code | Status | GTIN, EAN barcodes | Price | Prescribing | Reimbursement | Pack |
|---|---|---|---|---|---|---|
Keytruda 395mg/2.4ml solution for injection vials (Merck Sharp & Dohme (UK) Ltd) 1 vial45733011000001104 ref. pack | 💯 Available Legal category: POM | 003665825124790366582512479 | NHS Indicative Price £5,260 | • Hospital |
| — |
Reference packs
Pembrolizumab 395mg/2.4ml solution for injection vials 1 vial
- SNOMED code
45732811000001102- Quantity and unit
- 1 vial
- Packs